» Articles » PMID: 34840808

Challenges and Strategy in Treatment with Exosomes for Cell-free-based Tissue Engineering in Dentistry

Overview
Journal Future Sci OA
Specialty Biotechnology
Date 2021 Nov 29
PMID 34840808
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In dentistry, problems of craniofacial, osteochondral, periodontal tissue, nerve, pulp or endodontics injuries, and osteoarthritis need regenerative therapy. The use of stem cells in dental tissue engineering pays a lot of increased attention, but there are challenges for its clinical applications. Therefore, cell-free-based tissue engineering using exosomes isolated from stem cells is regarded an alternative approach in regenerative dentistry. However, practical use of exosome is restricted by limited secretion capability of cells. For future regenerative treatment with exosomes, efficient strategies for large-scale clinical applications are being studied, including the use of ceramics-based scaffold to enhance exosome production and secretion which can resolve limited exosome secretory from the cells when compared with the existing methods available. Indeed, more research needs to be done on these strategies going forward.

Citing Articles

Innovative approaches in lung tissue engineering: the role of exosome-loaded bioscaffolds in regenerative medicine.

Torkashvand M, Rezakhani L, Habibi Z, Mikaeili A, Rahmati S Front Bioeng Biotechnol. 2025; 12:1502155.

PMID: 39758953 PMC: 11695380. DOI: 10.3389/fbioe.2024.1502155.


Engineering Strategies of Plant-Derived Exosome-Like Nanovesicles: Current Knowledge and Future Perspectives.

Li Y, Wang Y, Zhao H, Pan Q, Chen G Int J Nanomedicine. 2024; 19():12793-12815.

PMID: 39640047 PMC: 11618857. DOI: 10.2147/IJN.S496664.


Exosome-Laden Hydrogels as Promising Carriers for Oral and Bone Tissue Engineering: Insight into Cell-Free Drug Delivery.

Villani C, Murugan P, George A Int J Mol Sci. 2024; 25(20).

PMID: 39456873 PMC: 11508290. DOI: 10.3390/ijms252011092.


Dental Stem Cell-Derived Exosomes: A Review of Their Isolation, Classification, Functions, and Mechanisms.

Ning X, Liu R, Huang Y, Huang Z, Li H, Li Q Stem Cells Int. 2024; 2024:2187392.

PMID: 39184549 PMC: 11343633. DOI: 10.1155/2024/2187392.


Anti-inflammatory potential of goldenberry-derived exosome-like nanoparticles in macrophage polarization.

Vanessa V, Rachmawati H, Barlian A Future Sci OA. 2024; 10(1):FSO943.

PMID: 38827806 PMC: 11140644. DOI: 10.2144/fsoa-2023-0172.


References
1.
Ilic N, Savic S, Siegel E, Atkinson K, Tasic L . Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis. Stem Cells Transl Med. 2013; 1(12):898-908. PMC: 3659669. DOI: 10.5966/sctm.2012-0037. View

2.
Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z . Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007; 18(6):1754-64. DOI: 10.1681/ASN.2007010044. View

3.
Xia B, Chen D, Zhang J, Hu S, Jin H, Tong P . Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014; 95(6):495-505. PMC: 4747051. DOI: 10.1007/s00223-014-9917-9. View

4.
Lund S, Giachelli C, Scatena M . The role of osteopontin in inflammatory processes. J Cell Commun Signal. 2009; 3(3-4):311-22. PMC: 2778587. DOI: 10.1007/s12079-009-0068-0. View

5.
Rouwkema J, Rivron N, van Blitterswijk C . Vascularization in tissue engineering. Trends Biotechnol. 2008; 26(8):434-41. DOI: 10.1016/j.tibtech.2008.04.009. View